A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose In the present study, human neural stem cells (hNSCs) with tumor-tropic behavior were used as drug delivery vehicle to selectively target melanoma. A hNSC line (HB1.F3) was transduced into two types: one expressed only the cytosine deaminase (CD) gene (HB1.F3. CD) and the other expressed both CD and human interferon-β (IFN-β) genes (HB1.F3.CD. IFN-β). Materials and Methods This study verified the tumor-tropic migratory competence of engineered hNSCs on melanoma (A375SM) using a modified Boyden chamber assay in vitro and CM-DiI staining in vivo. The antitumor effect of HB1.F3.CD and HB1.F3.CD.IFN-β on melanoma was also confirmed using an MTT assay in vitro and xenograft mouse models. Results A secreted form of IFN-β from the HB1.F3.CD.IFN-β cells modified the epithelial-mesenchymal transition (EMT) process and metastasis of melanoma. 5-Fluorouracil treatment also accelerated the expression of the pro-apoptotic protein BAX and decelerated the expression of the anti-apoptotic protein Bcl-xL on melanoma cell line. Conclusion Our results illustrate that engineered hNSCs prevented malignant melanoma cells from proliferating in the presence of the prodrug, and the form that secreted IFN-β intervened in the EMT process and melanoma metastasis. Hence, neural stem cell-directed enzyme/prodrug therapy is a plausible treatment for malignant melanoma.
Abstract
Purpose In the present study, human neural stem cells (hNSCs) with tumor-tropic behavior were used as drug delivery vehicle to selectively target melanoma. A hNSC line (HB1.F3) was transduced into two types: one expressed only the cytosine deaminase (CD) gene (HB1.F3. CD) and the other expressed both CD and human interferon-β (IFN-β) genes (HB1.F3.CD. IFN-β). Materials and Methods This study verified the tumor-tropic migratory competence of engineered hNSCs on melanoma (A375SM) using a modified Boyden chamber assay in vitro and CM-DiI staining in vivo. The antitumor effect of HB1.F3.CD and HB1.F3.CD.IFN-β on melanoma was also confirmed using an MTT assay in vitro and xenograft mouse models. Results A secreted form of IFN-β from the HB1.F3.CD.IFN-β cells modified the epithelial-mesenchymal transition (EMT) process and metastasis of melanoma. 5-Fluorouracil treatment also accelerated the expression of the pro-apoptotic protein BAX and decelerated the expression of the anti-apoptotic protein Bcl-xL on melanoma cell line. Conclusion Our results illustrate that engineered hNSCs prevented malignant melanoma cells from proliferating in the presence of the prodrug, and the form that secreted IFN-β intervened in the EMT process and melanoma metastasis. Hence, neural stem cell-directed enzyme/prodrug therapy is a plausible treatment for malignant melanoma.
참고문헌 (30)
- American Cancer Society, "Cancer facts and figures 2017" (2017), American Cancer Society
- Berwick M, "Melanoma epidemiology and prevention", Cancer Treat Res, 167, pp.17~49 (2016)
- Russak JE, "Risk factors for the development of primary cutaneous melanoma", Dermatol Clin, 30, pp.363~368 (2012)
- Marzagalli M, "Estrogen receptor beta in melanoma : from molecular insights to potential clinical utility", Front Endocrinol(Lausanne), 7, pp.140~ (2016)
- Han J, "Laparoscopic abdomino-perineal resection for patients with anorectal malignant melanoma : a report of 4 cases", J Biomed Res, 30, pp.436~440 (2016)
- Wellbrock C, "The complexity of the ERK", MAPkinase pathway and the treatment of melanoma skin cancer, 2016, pp.4, 33~
- Flaherty KT, "BRAF, a target in melanoma : implications for solid tumor drug development", Cancer, 116, pp.4902~4913 (2010)
- Funck-Brentano E, "Increase in NRAS mutant allele percentage during metastatic melanoma progression", Exp Dermatol, 25, pp.472~474 (2016)
- Kim T, "Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma", Cancer Biol Med, 11, pp.237~246 (2014)
- Yi BR, "Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-beta via their tumor-tropic effect in cellular and xenograft mouse models", Mol Oncol, 7, pp.543~554 (2013)
- Yi BR, "Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta via their tumor tropism to selectively target human hepatocarcinoma cells", Cancer Gene Ther, 19, pp.644~651 (2012)
- Hernandez-Alcoceba R, "Gene therapy of liver cancer", World J Gastroenterol, 12, pp.6085~6097 (2006)
- Yi BR, "Genetically engineered stem cells expressing cytosine deaminase and interferon-beta migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects", Int J Oncol, 39, pp.833~839 (2011)
- Garrison JI, "Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines", J Neurooncol, 30, pp.213~223 (1996)
- Ren C, "Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model", Gene Ther, 15, pp.1446~1453 (2008)
- Ito S, "Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma", Cancer Gene Ther, 17, pp.299~306 (2010)
- Yi BR, "Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice", Oncotarget, 5, pp.12835~12848 (2014)
- Aboody KS, "Stem and progenitor cellmediated tumor selective gene therapy", Gene Ther, 15, pp.739~752 (2008)
- Imitola J, "Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha", CXC chemokine receptor 4 pathway, 2004, pp.101, 18117~18122
- Schmidt NO, "Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor", Neoplasia, 7, pp.623~629 (2005)
- 박근태, "Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node–Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models", Cancer Research and Treatment, 49(1), pp.79~91 (2017), 대한암학회
- Yi BR, "Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models", Stem Cell Res, 12, pp.36~48 (2014)
- Meng WC, "Epirubicin-gold nanoparticles suppress hepatocellular carcinoma xenograft growth in nude mice", J Biomed Res, 29, pp.486~490 (2015)
- Mullen CA, "Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor", Cancer Res, 54, pp.1503~1506 (1994)
- Heo JR, "Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma(Review)", Oncol Rep, 36, pp.1779~1786 (2016)
- Bredholt G, "Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses", Oncotarget, 6, pp.39676~39691 (2015)
- Longley DB, "5-fluorouracil : mechanisms of action and clinical strategies", Nat Rev Cancer, 3, pp.330~338 (2003)
- Yi BR, "Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer", Oncotarget, 7, pp.5985~5999 (2016)
- Yi BR, "Additional effects of engineered stem cells expressing a therapeutic gene and interferon-beta in a xenograft mouse model of endometrial cancer", Int J Oncol, 47, pp.171~178 (2015)
- Kudryavets YI, "The role of interferon as a modifier of epithelial-mesenchymal transition in tumor cells", Exp Oncol, 33, pp.178~181 (2011)